Therapeutic antibodies are increasingly being used in the clinic for the treatment of various diseases. Yet, oral to gut targeting of antibodies remains a challenge due to their incapability to survive digestion and reach gastrointestinal tissues. Now, scientists have developed a new antibody technology that combines the advantages of antibody-based therapies with the convenience of oral drug administration.
Importantly, these antibodies are manufactured using yeast in a process as straight-forward as food-manufacturing. This work was published in the journal Nature Biotechnology. The antibody technology may have potential uses in various areas, from fighting veterinary and human gut infections, treating inflammatory and metabolic disorders, to the development of microbiome altering food supplements.
Now, researchers make oral to gut delivery of antibodies possible. The scientists engineered an antibody format that is simple but robust enough to survive the harsh environment in the gut. What is more, the team also developed a manufacturing process that uses either soybean seeds or yeast cells to produce these antibodies. By using existing food-processing technology they could eliminate the need for expensive purification processes. The result is an easily manufactured powder with antibodies that can be added to food and ingested orally, requiring no encapsulation.
The scientists obtained proof-of-concept with the technology in one of the target species, young piglets susceptible to a diarrhea-causing infection. Post-weaning diarrhea caused by enterotoxigenic Escherichia coli (ETEC) is an economically important disease in pig production worldwide. At the moment the only thing that helps against this infection is the use of antibiotics, which is a risk factor for the well-known problems of antibiotic resistance and potential transmission of resistant bacteria between animals and humans. This is a huge conundrum for pig producers, how to overcome ETEC crises in the face of strict regulatory limitations on the use of antibiotics for livestock. The new antibody-based approach appeared an effective and safe alternative. "The piglets, which were provided food supplemented with the new antibodies," the author says, "were protected against infection by ETEC in a pilot study." Given these results, the team is looking to further develop the antibodies as veterinary product.
Yet according to another author, who led the yeast work, the applications go much further. "Since the human and pig gut is strikingly similar, the lab is already exploring this technology for preventing and treating human gut infections and reducing symptoms in gastric diseases such as Crohn's disease and ulcerative colitis. One of the key contributions may be in humanitarian projects, for example during post-disaster situations to combat outbreaks of gut diseases such as cholera caused diarrhea." Overall, the versatility of this new technology creates novel product opportunities for use in different sectors, like food and feed additives, nutraceuticals, biopharmaceuticals, and microbiome optimization.
http://www.vib.be/en/news/Pages/Edible-antibodies-to-treat-and-prevent-gastrointestinal-disorders.aspx
https://www.nature.com/articles/s41587-019-0070-x
Latest News
DNA attached to nanoparticl…
By newseditor
Posted 29 Mar
Neighboring synapses shape…
By newseditor
Posted 29 Mar
Complete vascularization of…
By newseditor
Posted 28 Mar
Immune cells identified as…
By newseditor
Posted 28 Mar
TB blood test which could d…
By newseditor
Posted 27 Mar
Other Top Stories
AI can detect pneumonia in COVID-19 patients from CT scan
Read more
Bacterium Linked to Deadly Childhood Hydrocephalus Discovered!
Read more
Feeding C-section newborns with maternal fecal bacteria restores gu…
Read more
Gut microbe transcription suppressed by invading virus
Read more
Multiple sclerosis drug inhibits coronavirus in the lab studies
Read more
Protocols
Spatial proteomics in neuro…
By newseditor
Posted 28 Mar
All-optical presynaptic pla…
By newseditor
Posted 23 Mar
Epigenomic tomography for p…
By newseditor
Posted 20 Mar
A mouse DRG genetic toolkit…
By newseditor
Posted 17 Mar
An optogenetic method for t…
By newseditor
Posted 13 Mar
Publications
DNA corona on nanoparticles…
By newseditor
Posted 29 Mar
Co-dependent excitatory and…
By newseditor
Posted 29 Mar
A microfluidic platform int…
By newseditor
Posted 28 Mar
Salmonella manipulates macr…
By newseditor
Posted 28 Mar
BHLHE40/41 regulate microgl…
By newseditor
Posted 28 Mar
Presentations
Hydrogels in Drug Delivery
By newseditor
Posted 12 Apr
Lipids
By newseditor
Posted 31 Dec
Cell biology of carbohydrat…
By newseditor
Posted 29 Nov
RNA interference (RNAi)
By newseditor
Posted 23 Oct
RNA structure and functions
By newseditor
Posted 19 Oct
Posters
A chemical biology/modular…
By newseditor
Posted 22 Aug
Single-molecule covalent ma…
By newseditor
Posted 04 Jul
ASCO-2020-HEALTH SERVICES R…
By newseditor
Posted 23 Mar
ASCO-2020-HEAD AND NECK CANCER
By newseditor
Posted 23 Mar
ASCO-2020-GENITOURINARY CAN…
By newseditor
Posted 23 Mar